JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 2, 2004; DOI: 10.1124/jpet.104.066795


0022-3565/04/3102-536-545$20.00
JPET 310:536-545, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.066795v1
310/2/536    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gates, J.
Right arrow Articles by Apparsundaram, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gates, J., Jr.
Right arrow Articles by Apparsundaram, S.

CELLULAR AND MOLECULAR

Regulation of Choline Transporter Surface Expression and Phosphorylation by Protein Kinase C and Protein Phosphatase 1/2A

Jeremiah Gates, Jr., Shawn M. Ferguson, Randy D. Blakely, and Subbu Apparsundaram

Department of Anatomy and Neurobiology, University of Kentucky Medical Center, Lexington, Kentucky (J.G., S.A.); and Department of Pharmacology and Center for Molecular Neuroscience, Vanderbilt University Medical Center, Nashville, Tennessee (S.M.F., R.D.B.)

The Na+/Cl-dependent, hemicholinium-3-sensitive choline transporter (CHT) provides choline for acetylcholine biosynthesis. Recent studies show that CHT contains canonical protein kinase C (PKC) serine and threonine residues. We examined the ability of PKC and serine/threonine protein phosphatase 1/2A (PP1/PP2A) to regulate CHT function, surface expression, and phosphorylation. In mouse crude striatal and hippocampal synaptosomes, PKC activators {beta}-phorbol 12-myristate 13-acetate ({beta}-PMA) and {beta}-phorbol 12,13-dibutyrate produced time- and concentration-dependent reductions in CHT function. PP1/PP2A inhibitors okadaic acid (OKA) and calyculin A (CL-A) produced a time- and concentration-dependent decrease in CHT function. However, tautomycin (PP1 inhibitor) and cyclosporin A (PP2B inhibitor) failed to alter CHT-mediated choline uptake. Choline transport kinetic studies following {beta}-PMA, OKA, and CL-A treatment revealed a reduction in the maximal choline transport velocity (Vmax) with no change in Km for choline. These modulators also produced no change in the total levels of CHT protein in the crude hippocampal and striatal synaptosomes; however, surface biotinylation studies using the membrane-impermeant N-hydroxysuccinimide-biotin in crude synaptosomes following treatment with {beta}-PMA, OKA, and CL-A indicate significant reductions of CHT levels in biotinylated fractions. Pretreatment with OKA alone, but not {beta}-PMA, significantly augmented the phosphorylation level of CHT proteins. Our findings suggest that neuronal PKC and PP1/PP2A activity may establish the level of function and surface expression of CHT. These studies also provide the first evidence that CHT is a phosphoprotein and that the basal PP1/PP2A activity may have a dominant role in controlling the levels of CHT phosphorylation.


Received February 10, 2004; accepted April 2, 2004.

Address correspondence to: Dr. Subbu Apparsundaram, Anatomy and Neurobiology, 306 Whitney-Hendrickson Building, 800 Rose Street, University of Kentucky Medical Center, Lexington, KY 40536-0098. E-mail: subbu{at}uky.edu




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
M. Pinthong, S. A. G. Black, F. M. Ribeiro, C. Pholpramool, S. S. G. Ferguson, and R. J. Rylett
Activity and Subcellular Trafficking of the Sodium-Coupled Choline Transporter CHT Is Regulated Acutely by Peroxynitrite
Mol. Pharmacol., March 1, 2008; 73(3): 801 - 812.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. D. Fullerton, L. Wagner, Z. Yuan, and M. Bakovic
Impaired trafficking of choline transporter-like protein-1 at plasma membrane and inhibition of choline transport in THP-1 monocyte-derived macrophages
Am J Physiol Cell Physiol, April 1, 2006; 290(4): C1230 - C1238.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. Apparsundaram, V. Martinez, V. Parikh, R. Kozak, and M. Sarter
Increased Capacity and Density of Choline Transporters Situated in Synaptic Membranes of the Right Medial Prefrontal Cortex of Attentional Task-Performing Rats
J. Neurosci., April 13, 2005; 25(15): 3851 - 3856.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.